Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | SRA737 + STP-B |
Synonyms | |
Therapy Description | |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
SRA737 | CCT245737|CCT-245737 | CHK1 Inhibitor 18 | SRA737 (CCT245737) is a selective oral inhibitor of CHK1, which may enhance sensitivity of tumor cells to chemotherapeutics, thereby resulting in increased antitumor activity (PMID: 27167172, PMID: 31470128). | |
STP-B | STP-B inhibits CTPS1, which results in induction of DNA double-strand breaks, cell cycle arrest, and apoptosis, and potentially inhibits tumor growth (PMID: 37898670). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|